- Home
- FGNX vs TLPH Comparison
FGNX vs TLPH Comparison
Compare FGNX & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FGNX | TLPH |
|---|---|---|
| Founded | 1932 | 2005 |
| Country | United States | United States |
| Employees | 15 | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.1M | 42.3M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | FGNX | TLPH |
|---|---|---|
| Price | $7.30 | $0.81 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | ★ 172.7K | 130.7K |
| Earning Date | 05-19-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,151,000.00 |
| Revenue This Year | $650.31 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.59 | $0.38 |
| 52 Week High | $18.42 | $1.57 |
Technical Indicators
Market Signals| Indicator | FGNX | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 49.29 | 48.59 |
| Support Level | $5.89 | $0.73 |
| Resistance Level | $7.83 | $0.87 |
| Average True Range (ATR) | 0.83 | 0.06 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 39.14 | 28.13 |
Price Performance
Historical ComparisonAbout FGNX Fundamental Global Inc.
FG Nexus Inc operates through two primary segments: Digital Assets and Merchant Banking, with Digital Assets contributing the majority of revenue. The Company functions as a digital asset treasury, mainly holding Ethereum (ETH) and exploring opportunities in the tokenization of real-world assets, leveraging ETH as the foundation for digital finance, stablecoins, DeFi, and tokenized assets. The Merchant Banking segment offers strategic, administrative, and regulatory support to newly formed SPACs through the Company's SPAC platform.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.